Walshe M, Borowski K, Boland K, Rho S, et al. Ustekinumab induction concentrations are associated with clinical and biochemical outcomes at week 12 of treatment in Crohn's disease. Eur J Gastroenterol Hepatol 2021;33.
PMID: 33731595